NCT00289796View on ClinicalTrials.gov

Assess Feasibility of an Acellular Pertussis Vaccine (Pa) Given Soon After Birth, Followed by 3-dose Primary Vaccination With the DTPa-HBV-IPV/Hib Vaccine

PHASE2CompletedINTERVENTIONAL

Enrollment

121

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

April 30, 2006

Study Completion Date

December 31, 2006

Conditions

Hepatitis B

Interventions

BIOLOGICAL

DTPa-HBV-IPV/Hib

GSK Biologicals' combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b conjugate vaccine

Trial Locations (1)

55131

GSK Investigational Site, Mainz